Prospective Identification of Congenital Cytomegalovirus Infection in Newborns Using Real-Time Polymerase Chain Reaction Assays in Dried Blood Spots
Author(s) -
Marianne LeruezVille,
Christelle VauloupFellous,
Sophie Couderc,
S. Parat,
C. Castel,
Véronique Avettand-Fènoël,
Tiffany Guilleminot,
L. GrangeotKeros,
Y. Ville,
Sophie Grabar,
J.-F. Magny
Publication year - 2011
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciq241
Subject(s) - medicine , asymptomatic , cytomegalovirus , population , polymerase chain reaction , human cytomegalovirus , gold standard (test) , dried blood , betaherpesvirinae , prospective cohort study , dried blood spot , newborn screening , urine , predictive value , pediatrics , immunology , viral disease , herpesviridae , virus , biology , biochemistry , chemistry , genetics , environmental health , chromatography , gene
Congenital cytomegalovirus (CMV) infection is a public health issue, and implementation of neonatal screening has been debated. Detection of CMV DNA by polymerase chain reaction (PCR) of dried blood spots (DBS) routinely collected for metabolic screening from all newborns has been proposed for congenital CMV infection screening. The goal of this study was to prospectively assess the performance of 2 CMV PCR assays of DBS for CMV neonatal screening in a selected population of neonates.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom